Scinai Immunotherapeutics Ltd. (SCNI) — Shareholders' Equity
| Fiscal Year | Shareholders' Equity | Change YoY |
|---|---|---|
| 2025 | $8.10M | -18.8% |
| 2024 | $9.98M | +318.4% |
| 2023 | -$4.57M | -159.6% |
| 2022 | -$1.76M | -279.2% |
| 2021 | $982.0K | +106.5% |
| 2020 | -$15.04M | — |
| Fiscal Year | Shareholders' Equity | Change YoY |
|---|---|---|
| 2025 | $8.10M | -18.8% |
| 2024 | $9.98M | +318.4% |
| 2023 | -$4.57M | -159.6% |
| 2022 | -$1.76M | -279.2% |
| 2021 | $982.0K | +106.5% |
| 2020 | -$15.04M | — |